|
- Edwards Lifesciences - the leader in heart valves hemodynamic . . .
*Edwards Lifesciences Critical Care is now part of BD (Becton, Dickinson and Company) Patients We are dedicated to providing innovative solutions for people fighting cardiovascular disease
- Edwards Lifesciences Corp - Overview
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives
- Contact Us - Edwards Lifesciences
Careers at Edwards Discover an exciting career at a company dedicated to improving patient lives I'm a supplier Reach us here if you are, or would like to be, a supplier Other ways to reach us Patient Support Center Whether you are a patient or caring for one, we are here for you Give us a call or send us an email
- Who We Are - Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to
- Newsroom - Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to
- Locations - Edwards Lifesciences
Learn about our global locations and explore how our talented teams collaborate to meet our collective purpose of improving patients’ lives For a full list of all Edwards locations, click here
- Careers | Edwards Lifesciences
With more than 16,000 employees across the globe, we celebrate our inclusive culture and embrace the diverse perspectives and experiences of our Edwards team No matter your position or location, you will impact the future of our breakthrough medical technologies and industry
- Edwards Lifesciences Expands Structural Heart Portfolio With . . .
As the pioneer in valve innovation for more than 60 years, Edwards believes it is uniquely positioned to lead this next frontier of aortic valve disease treatment Edwards anticipates FDA approval of the JenaValve Trilogy Heart Valve System in late 2025, which will represent the first approved therapy for patients suffering from AR
|
|
|